pneumonia. J Clin Microbiol 50:7-15, 2012
2)Fujii T, et al:Pneumocystis pneumonia in patients with HIV infection;Clinical manifestations, laboratory findings, and radiological features. J Infect Chemother 13:1-7, 2007
3)Kovacs JA, Masur H:Evolving health effects of pneumocystis;One hundred years of progress in diagnosis and treatment. JAMA 301:2578-2585, 2009
pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 135:655-661, 2009
5)Kameda H, et al:Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents;Importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med 50:305-313, 2011
6)Thomas CF Jr, et al:Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients. UpToDate, Marr KA(ed), UpToDate, Waltham, MA, USA(accessed on February, 2016)
7)Klein NC, et al:Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients;Results of a large prospective randomized treatment trial. AIDS 6:301-305, 1992
8)Conte JE, et al:Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. Ann Intern Med 113:203-209, 1990
9)Schneider MM, et al:A controlled trial of aerosolized pentamizine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 327:1836-1841, 1992
1)ニューモシスチス肺炎研究会:ニューモシスチス肺炎のすべて,克誠堂出版,2014